These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8689242)

  • 1. N-cubylmethyl substituted morphinoids as novel narcotic antagonists.
    Cheng CY; Hsin LW; Lin YP; Tao PL; Jong TT
    Bioorg Med Chem; 1996 Jan; 4(1):73-80. PubMed ID: 8689242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine.
    Ward SJ; LoPresti D; James DW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):625-31. PubMed ID: 3016244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reversible binding of naloxazine and 14-hydroxydihydromorphazine with opiate receptors].
    Li LY; Ye CY; Zhang PW; Tian M; Jin YC
    Yao Xue Xue Bao; 1984 Apr; 19(4):251-5. PubMed ID: 6093431
    [No Abstract]   [Full Text] [Related]  

  • 9. Two new opioid delta-receptor ligands: a highly selective agonist and a potent selective antagonist in in vitro isolated preparations.
    Ueki M; Aoki K; Kajiwara M; Shinozaki K; Inoue H; Oka T
    Jpn J Pharmacol; 1984 Dec; 36(4):485-9. PubMed ID: 6098760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro pharmacological characterization of naloxone benzoylhydrazone.
    Berzetei-Gurske IP; White A; Polgar W; DeCosta BR; Pasternak GW; Toll L
    Eur J Pharmacol; 1995 Apr; 277(2-3):257-63. PubMed ID: 7493617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic regulation of the acute μ-withdrawal and CCk-8 contracture responses by the ORL-1 system in guinea pig ileum.
    Marini P; Romanelli L; Valeri D; Cascio MG; Tucci P; Valeri P; Palmery M
    Pharmacol Res; 2012 Jan; 65(1):100-10. PubMed ID: 21875667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TENA, a selective kappa opioid receptor antagonist.
    Portoghese PS; Takemori AE
    Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
    Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist Win 44,441-3.
    Ward SJ; Pierson AK; Michne WF
    Life Sci; 1983; 33 Suppl 1():303-6. PubMed ID: 6319882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro.
    Koman A; Kolb VM; Terenius L
    Pharm Res; 1987 Apr; 4(2):147-9. PubMed ID: 2855368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors.
    Portoghese PS; Larson DL; Sayre LM; Yim CB; Ronsisvalle G; Tam SW; Takemori AE
    J Med Chem; 1986 Oct; 29(10):1855-61. PubMed ID: 3020244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the narcotic receptor in the guinea-pig ileum.
    Ward A; Takemori AE
    J Pharmacol Exp Ther; 1976 Oct; 199(1):117-23. PubMed ID: 185357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.